Danish translation and linguistic validation of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

被引：0
|
作者：
Baeksted, Christina [1 ,2 ]
Nissen, Aase [2 ]
Pappot, Helle [3 ]
Bidstrup, Pernille E. [4 ]
Mitchell, Sandra A. [5 ]
Basch, Ethan [6 ]
Dalton, Susanne O. [4 ]
Johansen, Christoffer [7 ]
机构：
[1] Copenhagen Univ Hosp, Rigshosp, Publ Hlth, Copenhagen, Denmark
[2] Danish Canc Soc, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[4] Danish Canc Soc, Res Ctr, Copenhagen, Denmark
[5] NCI, Rockville, MD USA
[6] Univ N Carolina, Chapel Hill, NC USA
[7] Copenhagen Univ Hosp, Rigshosp, Med Sci, Copenhagen, Denmark
来源：
QUALITY OF LIFE RESEARCH | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
2047
引用
收藏
页码：121 / 122
页数：2
相关论文
共 50 条
  • [31] A pilot study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in a phase I clinical trial
    Qin, Rui
    Dueck, Amylou C.
    Satele, Daniel
    Molina, Julian R.
    Erlichman, Charles
    Basch, Ethan M.
    Sloan, Jeff A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] METHODS FOR REPORTING THE PATIENT-REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) DATA IN CANCER CLINICAL TRIALS
    Zhou, X.
    Eid, D.
    Gnanasakthy, A.
    VALUE IN HEALTH, 2018, 21 : S226 - S226
  • [33] Cultural adaptation of the Italian version o the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)
    Caminiti, Caterina
    Bryce, Jane
    Riva, Silvia
    Ng, Diane
    Diodati, Francesca
    Iezzi, Elisa
    Sparavigna, Lucia
    Novello, Silvia
    Porta, Camillo
    Del Mastro, Lucia
    Procopio, Giuseppe
    Cinieri, Saverio
    Falzetta, Amalia
    Calabro, Fabio
    Lorusso, Vito
    Cogoni, Alessio Aligi
    Tortora, Giampaolo
    Maruzzo, Marco
    Passalacqua, Rodolfo
    Cognetti, Francesco
    Adamo, Vincenzo
    Capelletto, Enrica
    Ferrari, Alessandra
    Bagnalasta, Michela
    Bassi, Maurizio
    Nicelli, Annalisa
    De Persis, Davide
    D'Acunti, Alessia
    Iannelli, Elisabetta
    Perrone, Francesco
    Mitchell, Sandra A.
    TUMORI JOURNAL, 2023, 109 (03): : 324 - 334
  • [34] Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Bruner, Deborah Watkins
    Hanisch, Laura J.
    Reeve, Bryce B.
    Trotti, Andy M.
    Schrag, Deborah
    Sit, Laura
    Mendoza, Tito R.
    Minasian, Lori
    O'Mara, Ann
    Denicoff, Andrea M.
    Rowland, Julia H.
    Montello, Michael
    Geoghegan, Cindy
    Abernethy, Amy P.
    Clauser, Steven B.
    Castro, Kathleen
    Mitchell, Sandra A.
    Burke, Laurie
    Trentacosti, Ann Marie
    Basch, Ethan M.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2011, 1 (01) : 110 - 122
  • [35] Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials Comment
    Basch, Ethan
    Thanarajasingam, Gita
    Dueck, Amylou C.
    CLINICAL TRIALS, 2022, 19 (03) : 274 - 276
  • [36] Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Wang, Tian Qi
    Samuel, Joseph N.
    Brown, M. Catherine
    Vennettilli, Ashlee
    Solomon, Hannah
    Eng, Lawson
    Liang, Mindy
    Gill, Gursharan
    Merali, Zahra
    Tian, Chenchen
    Cheng, Nicholas Y. H.
    Campbell, Matthew
    Patel, Devalben
    Liu, Ai Xin
    Liu, Geoffrey
    Howell, Doris
    ONCOLOGY AND THERAPY, 2018, 6 (02) : 189 - 201
  • [37] Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC)
    Nichols, Christine
    Mitchell, Sandra A.
    Lang, Kathy
    Federico, Victoria
    Castro, Kathleen M.
    Rogak, Lauren J.
    Lalla, Deepa
    Clauser, Steven B.
    Reeve, Bryce B.
    Denicoff, Andrea
    Chen, Alice P.
    Piekarz, Richard
    Atkinson, Thomas Michael
    Mayer, Musa
    Brammer, Melissa G.
    Sit, Laura
    O'Mara, Ann M.
    Minasian, Lori M.
    Basch, Ethan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Dueck, Amylou C.
    Mendoza, Tito R.
    Mitchell, Sandra A.
    Reeve, Bryce B.
    Castro, Kathleen M.
    Rogak, Lauren J.
    Atkinson, Thomas M.
    Bennett, Antonia V.
    Denicoff, Andrea M.
    O'Mara, Ann M.
    Li, Yuelin
    Clauser, Steven B.
    Bryant, Donna M.
    Bearden, James D., III
    Gillis, Theresa A.
    Harness, Jay K.
    Siegel, Robert D.
    Paul, Diane B.
    Cleeland, Charles S.
    Schrag, Deborah
    Sloan, Jeff A.
    Abernethy, Amy P.
    Bruner, Deborah W.
    Minasian, Lori M.
    Basch, Ethan
    JAMA ONCOLOGY, 2015, 1 (08) : 1051 - 1059
  • [39] Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Hay, Jennifer L.
    Atkinson, Thomas M.
    Reeve, Bryce B.
    Mitchell, Sandra A.
    Mendoza, Tito R.
    Willis, Gordon
    Minasian, Lori M.
    Clauser, Steven B.
    Denicoff, Andrea
    O'Mara, Ann
    Chen, Alice
    Bennett, Antonia V.
    Paul, Diane B.
    Gagne, Joshua
    Rogak, Lauren
    Sit, Laura
    Viswanath, Vish
    Schrag, Deborah
    Basch, Ethan
    QUALITY OF LIFE RESEARCH, 2014, 23 (01) : 257 - 269
  • [40] Landscape review of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in oncology: Adoption and recent learnings.
    Regnault, Antoine
    Quere, Stephane
    Gorsh, Boris
    Sapra, Sandhya
    Loubert, Angely
    Davis, Randy
    Nelsen, Linda
    Cardellino, Anna
    Eliason, Laurie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345